Is the pharma manufacturing company that you work with Schedule M compliant? No matter how long they have been serving you, it is important to ensure that they are following these important guidelines.
If you are new to Schedule M, this guide will assist you to know the key aspects of it.
What is Schedule M?
Schedule M is a section of the Drugs and Cosmetics Rules, 1945. It was introduced in 1988. It has been substantially revised in 2001 and 2023. Today, it serves as the official rulebook that pharmaceutical companies in India must follow.
Schedule M defines safety and cleanliness standards for manufacturing medicines. This update helps Indian pharmaceutical companies to follow global standards like WHO-GMP and EU-GMP more closely.
You, as a distributor, a vendor or a pharmacist, make sure to work with a Schedule M compliant pharma manufacturing unit. There are several guidelines that define a Schedule M compliant pharma unit.
Core Requirements to Become a Schedule M Compliant Pharma Unit
Here are some key Schedule M guidelines for pharma manufacturing companies.
1. Facility & Premises (Building & Plant Set-up)
A medicine factory isn’t just some random building. It should be designed to keep contaminants out.
- Location: The plant should be located away from dirty places like open drains, chemical smoke or too much dust.
- Flow of Materials: Materials should move in a logical and one-way direction. Raw chemical powders should go in one side, go to processing, go to packaging and leave as finished products without backtracking. This avoids confusion.
- Walls and Floors: Production areas shall be smooth, washable and constructed of materials that will not shed particles or dust.
2. Machine and Utilities
There are strict rules for the design of tools for mixing, compressing or filling drugs.
- Safe Materials: All parts of the machine that will come in contact with the medicine should be made of non-reactive materials such as high-grade stainless steel to avoid rust or change in chemical formula.
- Validation: Manufacturers validate their equipment using Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). These processes are important to find out if a machine is installed properly and it works well under pressure.
- Air and Water Systems: Sophisticated systems such as HVAC (Heating, Ventilation and Air Conditioning) are required to control the temperature, humidity and pressure of clean air in the room.
3. Personnel (People & Training)
A manufacturer should have qualified people in important sections like production and quality assurance departments. Secondly, all workers are required to wear clean room suits, masks, and gloves. Also, the manufacturer should carry out health checks regularly. This helps to prevent any infections from entering the sterile zones.
4. Documentation
Every batch of medicine requires a Batch Manufacturing Record (BMR), a clear paper trail or digital log.
New rules require data to be ALCOA+ compliant. This means that your data has to be:
- Attributable: The manufacturer should be aware of who created it.
- Easy to read: It’s readable.
- Contemporaneous: Recorded at the precise time the work occurred, not completed at the end of the day.
5. Quality Management System (QMS)
A QMS is an internal system to find and fix mistakes. If a machine temperature spikes or a batch fails a test, medicine manufacturers have to log a deviation (an unexpected event). Then they need to run a CAPA (Corrective and Preventive Action) plan to correct the root cause, so the mistake never happens again.
DM Pharma: Your Trusted Schedule M Certified Pharma Unit
These tough international standards require costly upgrades to your own factory, which can cause some downtime in production. This is why many emerging pharmaceutical brands choose to outsource their manufacturing instead.
Seeking a trusted partner already working at full compliance? DM Pharma is the answer. DM Pharma is a WHO-GMP-certified third-party and contract pharmaceutical manufacturer in India. And we are a fully Schedule M Compliant Pharma unit.
As a trusted Schedule M Certified Pharma Unit, we run the most modern plants in compliance with national and international safety rules. DM Pharma offer cost-effective contract manufacturing of tablets, capsules, syrups, dry syrups and cosmetics that allow businesses to roll out high-quality products at a fast pace without massive capital expenditure on building their own plants. We have strict in-house quality control labs and batch-wise testing to ensure your brand is completely compliant with global standards.
The Bottom Line
The shift towards a Schedule M compliant pharma unit could be intimidating initially. The call is for investment in better infrastructure, digital software, and tight staff discipline. But in the long term, it protects any pharma manufacturing business from legal trouble, reduces wasted batches and ensures they are delivering safe, world-class medicines to patients, pharmacists, and distributors.
Frequently Asked Questions
Q1. What is Schedule M?
Schedule M is a section of the Drugs and Cosmetics Rules, 1945. It was introduced in 1988.
Q2. What if a pharmaceutical operation is not Schedule M compliant?
State drug regulators can suspend or revoke a manufacturing license if the facility does not comply with the revised Schedule M guidelines. Until you fix the problems and pass a re-inspection, you cannot make or sell medicine. Therefore, a Schedule M compliant pharma unit has to follow guidelines.
Q3. Are Schedule M and WHO-GMP the same?
They are alike, but not the same. India has Schedule M as the specific national law. However, the latest revised Schedule M has been rewritten to follow the WHO-GMP standards closely and makes it much easier for Indian plants to qualify for international export.
Q4. What is a Batch Manufacturing Record (BMR)?
A BMR is a step-by-step record of the whole history of one single batch of medicine. It records the raw material weights, mixing times, machine speeds, temperatures and the signatures of the workers who performed each task.
Q5. When should a pharma unit conduct self-inspections?
The new QMS guidelines require that a conforming unit conduct regular internal audits or self-inspections at specified intervals (usually quarterly or biannually) to find errors proactively before official regulatory officers do.